poisar

Stocks · News reference

Raymond James Downgrades Alignment Healthcare to Outperform, Lowers Price Target to $19

Benzinga Newsdesk

Raymond James analyst John Ransom downgrades Alignment Healthcare (NASDAQ:ALHC) from Strong Buy to Outperform and lowers the price target from $22 to $19.

More stocks newsConnected markets

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

ALHC
Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Na

    Alignment Health’s Fifth Annual Survey Finds Seniors Falling Further Behind: Aging in Place Challenges Continue to Rise as Support Gaps Widen

    Alignment Health's 2026 survey reveals that 90% of seniors face at least one social barrier to healthy aging, with aging-in-place challenges, healthcare access issues, and economic instability as top concerns. The study shows worsening trends year-over-year, including increased difficulty maintaining independence and rising medical debt. Over one-quarter of seniors skipped needed medical care, with 34% citing aging-in-place challenges as the reason.

    ALHC
  2. Not Specified

    Alignment Health Plan and Hoag Health System Increase Access to Award-Winning Care for Orange County Seniors

    Alignment Health Plan announced an expanded partnership with Hoag Health System effective January 1, 2027, providing Medicare Advantage members in Orange County with in-network access to Hoag's physicians, hospitals, specialty programs, and urgent care facilities. The collaboration aims to improve healthcare access and affordability for seniors by combining Alignment's care model with Hoag's extensive local provider network.

    ALHC
  3. Kaplan Fox & Kilsheimer Llp

    Kaplan Fox is Investigating Alignment Healthcare, Inc. (NASDAQ: ALHC) and Certain of its Officers and Directors for Potential Securities Law Violations

    Law firm Kaplan Fox is investigating Alignment Healthcare (ALHC) for potential securities violations following a whistleblower complaint alleging accounting irregularities and misclassification of operating expenses as capital expenditures. The allegations artificially inflated the company's financial results and Adjusted EBITDA metrics. ALHC stock fell 16.7% on July 8, 2026, following the news.

    ALHC